George Perry to Amyloidogenic Proteins
This is a "connection" page, showing publications George Perry has written about Amyloidogenic Proteins.
Connection Strength
0.280
-
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes. J Alzheimers Dis. 2023; 94(2):497-507.
Score: 0.195
-
Passive Alzheimer's immunotherapy: A promising or uncertain option? Ageing Res Rev. 2023 09; 90:101996.
Score: 0.051
-
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model. Hum Mol Genet. 2017 11 01; 26(21):4118-4131.
Score: 0.034